The perception that cord blood is an inferior source of stem cells is simply not accurate and may result in delays in lifesaving treatment for patients.
Colleen S. Delaney, MD, MSC
Advertisement
Articles by Colleen S. Delaney, MD, MSC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Breakthrough Therapy Designation to JBS-003 for Radiation De-Escalation in HPV+ Oropharyngeal Cancer
2
August Roundup of FDA Approvals in Oncology: Daraxonrasib Highlights 5 Decisions to Know
3
New Biomarker-Driven Regimens Prompt Debate Over Treatment Intensification in Advanced Prostate Cancer
4
Etentamig Meets PFS, ORR Primary End Points in Triple-Class Exposed R/R Myeloma
5